Cargando…

A Quality Improvement Initiative to Decrease Time to Antibiotics for Children with Intestinal Failure, Fever, and a Central Line

INTRODUCTION: Pediatric intestinal failure (IF) patients experience significant morbidity, including sepsis related to central line–associated bloodstream infections. Adult studies of sepsis demonstrate an association between time to antibiotic administration (TTA) and mortality. To overcome challen...

Descripción completa

Detalles Bibliográficos
Autores principales: Hariharan, Selena, Mezoff, Ethan A., Dandoy, Christopher E., Zhang, Yue, Chiarenzelli, Janis, Troutt, Misty L., Simpkins, Jean, Dewald, Mary, Klotz, Kim, Mezoff, Adam G., Cole, Conrad R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135554/
https://www.ncbi.nlm.nih.gov/pubmed/30229201
http://dx.doi.org/10.1097/pq9.0000000000000090
_version_ 1783354846712168448
author Hariharan, Selena
Mezoff, Ethan A.
Dandoy, Christopher E.
Zhang, Yue
Chiarenzelli, Janis
Troutt, Misty L.
Simpkins, Jean
Dewald, Mary
Klotz, Kim
Mezoff, Adam G.
Cole, Conrad R.
author_facet Hariharan, Selena
Mezoff, Ethan A.
Dandoy, Christopher E.
Zhang, Yue
Chiarenzelli, Janis
Troutt, Misty L.
Simpkins, Jean
Dewald, Mary
Klotz, Kim
Mezoff, Adam G.
Cole, Conrad R.
author_sort Hariharan, Selena
collection PubMed
description INTRODUCTION: Pediatric intestinal failure (IF) patients experience significant morbidity, including sepsis related to central line–associated bloodstream infections. Adult studies of sepsis demonstrate an association between time to antibiotic administration (TTA) and mortality. To overcome challenges in treating pediatric IF patients in an emergency department (ED), we appropriated an existing, reliable system for febrile immunocompromised oncology/bone marrow transplant children. We describe the translation of this process to febrile IF patients in the ED and steps toward sustained improvement. METHODS: We formed a multidisciplinary team and used the Model for Improvement to define aims and identify key drivers. The goal was to use an existing improvement process to increase the percentage of patients with IF who receive antibiotics within 60 minutes of arrival to the ED from 46% to 90%. Key drivers included pre- and postarrival processes, staff and family engagement, and a preoccupation with failure. We performed Plan-Do-Study-Act cycles targeting family engagement, prearrival efficiency, and postarrival consistency. RESULTS: Two hundred seventy-six encounters involving febrile IF patients between November 2012 and March 2017 were evaluated. There was a sustained reduction in the median time from arrival to antibiotic administration (71–45 minutes). We decreased TTA to less than 60 minutes for 77% of febrile IF patients. CONCLUSIONS: The basic tenets of process improvement for 1 high-risk population can be translated to another high-risk population but must be adjusted for variability in characteristics.
format Online
Article
Text
id pubmed-6135554
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-61355542018-09-18 A Quality Improvement Initiative to Decrease Time to Antibiotics for Children with Intestinal Failure, Fever, and a Central Line Hariharan, Selena Mezoff, Ethan A. Dandoy, Christopher E. Zhang, Yue Chiarenzelli, Janis Troutt, Misty L. Simpkins, Jean Dewald, Mary Klotz, Kim Mezoff, Adam G. Cole, Conrad R. Pediatr Qual Saf Individual QI Projects from Single Institutions INTRODUCTION: Pediatric intestinal failure (IF) patients experience significant morbidity, including sepsis related to central line–associated bloodstream infections. Adult studies of sepsis demonstrate an association between time to antibiotic administration (TTA) and mortality. To overcome challenges in treating pediatric IF patients in an emergency department (ED), we appropriated an existing, reliable system for febrile immunocompromised oncology/bone marrow transplant children. We describe the translation of this process to febrile IF patients in the ED and steps toward sustained improvement. METHODS: We formed a multidisciplinary team and used the Model for Improvement to define aims and identify key drivers. The goal was to use an existing improvement process to increase the percentage of patients with IF who receive antibiotics within 60 minutes of arrival to the ED from 46% to 90%. Key drivers included pre- and postarrival processes, staff and family engagement, and a preoccupation with failure. We performed Plan-Do-Study-Act cycles targeting family engagement, prearrival efficiency, and postarrival consistency. RESULTS: Two hundred seventy-six encounters involving febrile IF patients between November 2012 and March 2017 were evaluated. There was a sustained reduction in the median time from arrival to antibiotic administration (71–45 minutes). We decreased TTA to less than 60 minutes for 77% of febrile IF patients. CONCLUSIONS: The basic tenets of process improvement for 1 high-risk population can be translated to another high-risk population but must be adjusted for variability in characteristics. Wolters Kluwer Health 2018-07-20 /pmc/articles/PMC6135554/ /pubmed/30229201 http://dx.doi.org/10.1097/pq9.0000000000000090 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Individual QI Projects from Single Institutions
Hariharan, Selena
Mezoff, Ethan A.
Dandoy, Christopher E.
Zhang, Yue
Chiarenzelli, Janis
Troutt, Misty L.
Simpkins, Jean
Dewald, Mary
Klotz, Kim
Mezoff, Adam G.
Cole, Conrad R.
A Quality Improvement Initiative to Decrease Time to Antibiotics for Children with Intestinal Failure, Fever, and a Central Line
title A Quality Improvement Initiative to Decrease Time to Antibiotics for Children with Intestinal Failure, Fever, and a Central Line
title_full A Quality Improvement Initiative to Decrease Time to Antibiotics for Children with Intestinal Failure, Fever, and a Central Line
title_fullStr A Quality Improvement Initiative to Decrease Time to Antibiotics for Children with Intestinal Failure, Fever, and a Central Line
title_full_unstemmed A Quality Improvement Initiative to Decrease Time to Antibiotics for Children with Intestinal Failure, Fever, and a Central Line
title_short A Quality Improvement Initiative to Decrease Time to Antibiotics for Children with Intestinal Failure, Fever, and a Central Line
title_sort quality improvement initiative to decrease time to antibiotics for children with intestinal failure, fever, and a central line
topic Individual QI Projects from Single Institutions
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135554/
https://www.ncbi.nlm.nih.gov/pubmed/30229201
http://dx.doi.org/10.1097/pq9.0000000000000090
work_keys_str_mv AT hariharanselena aqualityimprovementinitiativetodecreasetimetoantibioticsforchildrenwithintestinalfailurefeverandacentralline
AT mezoffethana aqualityimprovementinitiativetodecreasetimetoantibioticsforchildrenwithintestinalfailurefeverandacentralline
AT dandoychristophere aqualityimprovementinitiativetodecreasetimetoantibioticsforchildrenwithintestinalfailurefeverandacentralline
AT zhangyue aqualityimprovementinitiativetodecreasetimetoantibioticsforchildrenwithintestinalfailurefeverandacentralline
AT chiarenzellijanis aqualityimprovementinitiativetodecreasetimetoantibioticsforchildrenwithintestinalfailurefeverandacentralline
AT trouttmistyl aqualityimprovementinitiativetodecreasetimetoantibioticsforchildrenwithintestinalfailurefeverandacentralline
AT simpkinsjean aqualityimprovementinitiativetodecreasetimetoantibioticsforchildrenwithintestinalfailurefeverandacentralline
AT dewaldmary aqualityimprovementinitiativetodecreasetimetoantibioticsforchildrenwithintestinalfailurefeverandacentralline
AT klotzkim aqualityimprovementinitiativetodecreasetimetoantibioticsforchildrenwithintestinalfailurefeverandacentralline
AT mezoffadamg aqualityimprovementinitiativetodecreasetimetoantibioticsforchildrenwithintestinalfailurefeverandacentralline
AT coleconradr aqualityimprovementinitiativetodecreasetimetoantibioticsforchildrenwithintestinalfailurefeverandacentralline
AT hariharanselena qualityimprovementinitiativetodecreasetimetoantibioticsforchildrenwithintestinalfailurefeverandacentralline
AT mezoffethana qualityimprovementinitiativetodecreasetimetoantibioticsforchildrenwithintestinalfailurefeverandacentralline
AT dandoychristophere qualityimprovementinitiativetodecreasetimetoantibioticsforchildrenwithintestinalfailurefeverandacentralline
AT zhangyue qualityimprovementinitiativetodecreasetimetoantibioticsforchildrenwithintestinalfailurefeverandacentralline
AT chiarenzellijanis qualityimprovementinitiativetodecreasetimetoantibioticsforchildrenwithintestinalfailurefeverandacentralline
AT trouttmistyl qualityimprovementinitiativetodecreasetimetoantibioticsforchildrenwithintestinalfailurefeverandacentralline
AT simpkinsjean qualityimprovementinitiativetodecreasetimetoantibioticsforchildrenwithintestinalfailurefeverandacentralline
AT dewaldmary qualityimprovementinitiativetodecreasetimetoantibioticsforchildrenwithintestinalfailurefeverandacentralline
AT klotzkim qualityimprovementinitiativetodecreasetimetoantibioticsforchildrenwithintestinalfailurefeverandacentralline
AT mezoffadamg qualityimprovementinitiativetodecreasetimetoantibioticsforchildrenwithintestinalfailurefeverandacentralline
AT coleconradr qualityimprovementinitiativetodecreasetimetoantibioticsforchildrenwithintestinalfailurefeverandacentralline